Vanguard Capital Management’s Arcadia Biosciences RKDA Stock Holding History
Bought
Maintained
Sold
Other funds holding RKDA
BWM
Vanguard Capital Management's RKDA Position: Q3 2026 in Review
Vanguard Capital Management held its Arcadia Biosciences (RKDA) position steady in Q3 2026 at 9,644 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4052.
Vanguard Capital Management first reported a position in RKDA in Q1 2026 and has held it in 3 quarters since. The position peaked at $13.3K in Q1 2026. 19 funds tracked by Wall St. Rank hold RKDA as of Q3 2026.
- Vanguard Capital Management held 9,644 shares of Arcadia Biosciences worth $2.7K as of Q3 2026.
- Vanguard Capital Management left its Arcadia Biosciences share count unchanged in Q3 2026.
- Arcadia Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4052 holding.
- Vanguard Capital Management first reported a position in Arcadia Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Arcadia Biosciences position peaked at $13.3K in Q1 2026.
- 19 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.